Big Pharma can gain from tango with small fry - 1 year ago
Indias largest pharmaceutical industry body, the Indian Drug Manufacturers Association, presents a picture of vivid contrasts.
Clinical trials in India a delicate line to tread - 1 year ago
What started as a rare reporting subject only a few years ago has become a frequent fixture for newspapers and magazines ethics in clinical trials in India.
Comment: As pharma buyouts taper, focus shifts to smaller firms - 1 year ago
While cross-border deals did not completely subside in the last one year, a long pause is becoming apparent.
Affordable medicines will take more than price controls - 1 year ago
The draft National Pharmaceutical Pricing Policy floated in October by the Department of Pharmaceuticals inviting feedback from stakeholders charts out significant changes
Make no mistake, multinational drugmakers are very alive to markets such as India - 3 years ago
Department of Industrial Policy and Promotions apprehension that these companies will ignore local needs and focus only on exports is unfounded.
Genzyme is just the booster that Sanofi Aventis needs now - 3 years ago
Orphan-drug maker, with a strong pipeline and sales of $4.5 billion, will be a prize catch
Government alone cant fight cancer, diabetes and strokes - 3 years ago
There should be all-round effort and companies should think beyond the bottomline.
Despite FDA vote, the words caution on Avandia - 3 years ago
Its important to put the safety of the patients before any opinion is shared arbitrarily.
Move to better access to drugs a welcome change - 3 years ago
Study shows greater willingness among companies to open up
Stage set for bigger biotechnology play by local companies - 3 years ago
If they surmount the development and launch hiccups, it could well be generics redux.